SCHEMBL525240

SCHEMBL525240

O=C(CCCCCCCCC(=O)OC1CCCCC1)OC1CCCCC1

nearest known ligand 0.82

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 2/20 0.82
SMN1; SMN2 Q16637 2/20 0.54
CYP2C19 P33261 1/20 0.52
HTT P42858 2/20 0.49
CYP19A1 P11511 2/20 0.46
EPHX1 P07099 2/20 0.46
EPHX2 P34913 2/20 0.42
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41
HPGD P15428 1/20 0.41
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
PDE3B Q13370 1/20 0.37
PDE3A Q14432 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1681692 1.00 NAAA (0.82) NAAASMN1; SMN2CYP2C19HTTCYP19A1
SCHEMBL9490272 1.00 NAAA (0.82) NAAASMN1; SMN2CYP2C19HTTCYP19A1
SCHEMBL27965233 1.00 NAAA (0.82) NAAASMN1; SMN2CYP2C19HTTCYP19A1
SCHEMBL9488891 1.00 NAAA (0.82) NAAASMN1; SMN2CYP2C19HTTCYP19A1
SCHEMBL31069919 1.00 NAAA (0.82) NAAASMN1; SMN2CYP2C19HTTCYP19A1
SCHEMBL15987690 1.00 NAAA (0.82) NAAASMN1; SMN2CYP2C19HTTCYP19A1
SCHEMBL28060851 1.00 NAAA (0.82) NAAASMN1; SMN2CYP2C19HTTCYP19A1
SCHEMBL207867 0.98 NAAA (0.79) NAAASMN1; SMN2CYP2C19HTTCYP19A1
SCHEMBL17675641 0.98 NAAA (0.79) NAAASMN1; SMN2CYP2C19HTTCYP19A1
SCHEMBL31069915 0.98 NAAA (0.81) NAAASMN1; SMN2CYP2C19HTTCYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3802896-A1 LOW GAUGE, LEVELLED CAN BODY STOCK AND METHODS OF MAKING THE SAME Novelis, Inc. (US) 2021-04-14 EP claimed
US-4085080-A Nylon composition containing non-polar ester plasticizer MONSANTO COMPANY (US) 1978-04-18 US claimed
US-20260063999-A1 NEGATIVE PHOTOSENSITIVE RESIN COMPOSITION, PRODUCTION METHOD FOR POLYIMIDE CURED FILM USING SAME, AND POLYIMIDE CURED FILM ASAHI KASEI KABUSHIKI KAISHA (JP) 2026-03-05 US disclosed
CN-120129876-A Negative photosensitive resin composition, method for producing polyimide cured film using same, and polyimide cured film 旭化成株式会社 2025-06-10 CN disclosed
CN-119186570-A Low-temperature CO2Hydrogenation methanol preparation catalyst, preparation and application 上海华谊控股集团有限公司 2024-12-27 CN disclosed
CN-118938601-A Negative photosensitive resin composition and method for producing cured relief pattern 旭化成株式会社 2024-11-12 CN disclosed
WO-2024225072-A1 PHOTOSENSITIVE RESIN COMPOSITION, PRODUCTION METHOD FOR CURED RELIEF PATTERN, AND CURED FILM 旭化成株式会社 2024-10-31 WO disclosed
WO-2024219463-A1 NEGATIVE PHOTOSENSITIVE RESIN COMPOSITION, METHOD FOR PRODUCING CURED RELIEF PATTERN USING SAME, AND CURED FILM 旭化成株式会社 2024-10-24 WO disclosed
WO-2024210063-A1 PHOTOSENSITIVE RESIN COMPOSITION, METHOD FOR PRODUCING CURED RELIEF PATTERN, CURED FILM, AND SEMICONDUCTOR DEVICE 旭化成株式会社 2024-10-10 WO disclosed
US-11787918-B2 Biobased compositions Evoco Limited (CA) 2023-10-17 US disclosed
WO-2022174333-A1 BIOBASED COMPOSITIONS Evoco Limited (CA) 2022-08-25 WO disclosed
EP-0922072-B1 FLAME RETARDANT COMPOSITION DU PONT (US) 2002-10-23 EP disclosed
US-6015510-A COMPRISING COATED PARTICLES HAVING CORE MATERIAL SELECTED FROM THE GROUP CONSISTING OF MELAMINE POLYPHOSPHATE, MELAMINE PYROPHOSPHATE, AND MIXTURES THEREOF HAVING COATING SELECTED FROM THE GROUP CONSISTING OF SILANE, ESTER, DIANHYDRIDE, E. I. DU PONT DE NEMOURS AND COMPANY (US) 2000-01-18 US disclosed
US-5998503-A MELAMINE (POLY OR PYRO)PHOSPHATE CORE OVERCOATED WITH POLYMER E. I. DU PONT DE NEMOURS AND COMPANY (US) 1999-12-07 US disclosed
EP-0922072-A1 FLAME RETARDANT COMPOSITION E.I. DU PONT DE NEMOURS AND COMPANY (US) 1999-06-16 EP disclosed
WO-1998008898-A1 FLAME RETARDANT COMPOSITION E.I. DU PONT DE NEMOURS AND COMPANY (US) 1998-03-05 WO disclosed
US-5643592-A TITANIUM DIOXIDE PARTICLES WITH INORGANIC SURFACE COATINGS AND COLORED PIGMENTS WITH DIESTERS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1997-07-01 US disclosed
EP-0693096-A1 SURFACE-COATED PARTICULATE ADDITIVES FOR POLYMERS DU PONT (US) 1996-01-24 EP disclosed
WO-1994022962-A1 SURFACE-COATED PARTICULATE ADDITIVES FOR POLYMERS E.I. DU PONT DE NEMOURS AND COMPANY (US) 1994-10-13 WO disclosed
US-4085080-A Nylon composition containing non-polar ester plasticizer MONSANTO COMPANY (US) 1978-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260063999-A1 NEGATIVE PHOTOSENSITIVE RESIN COMPOSITION, PRODUCTION METHOD FOR POLYIMIDE CURED FILM USING SAME, AND POLYIMIDE CURED FILM ARCN1, PBRM1, LCP1 NAAA 772/4885SMN1; SMN2 2062/4885CYP2C19 4123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.